Navigation Links
Biothera's Imprime PGG Enhanced Effectiveness of Avastin in Cancer,Study

e I clinical trials under its cancer Investigational New Drug (IND) application for the use of Imprime PGG in combination with anti-cancer monoclonal antibodies. Under a separate IND, the company also has completed a Phase I/II trial with Imprime PGG in combination with a hematopoietic growth factor.

Biothera plans to initiate multiple Phase Ib and Phase II studies with Imprime PGG in combination with anti-cancer monoclonal antibodies.

About Avastin(R)

Avastin is the first U.S. Food and Drug Administration (FDA) approved therapy designed to inhibit angiogenesis, the process by which new blood vessels develop and carry vital nutrients to a tumor. Avastin is approved, in combination with intravenous 5-fluorouracil-based (5-FU) chemotherapy, for first- or second-line treatment of patients with metastatic carcinoma of the colon or rectum and in combination with carboplatin and paclitaxel for the first-line treatment of patients with unresectable, locally advanced, recurrent or metastatic non-squamous non-small cell lung cancer (NSCLC). Avastin is a product of Genentech.

About Biothera, the Immune Health Company

Biothera is a biotechnology company dedicated to improving immune health. The company's primary focus is developing pharmaceuticals that engage the innate immune system to fight cancer. Other applications include hematopoiesis (production of blood cells) and infectious disease. In addition, Biothera manufactures and markets food-grade ingredients that support healthy immune function to the nutritional supplement, functional food, cosmetic and animal nutrition markets. Website: www.biotherapharma.com.

Contact

Biothera, the Immune Health Company
David Walsh, 651-256-4606
VP, Communications
dwalsh@biotherapharma.com


'"/>




Page: 1 2

Related medicine technology :

1. Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with Electroporation DNA Delivery Technology and New Devices at Gene Therapy Meeting
2. Favrille Announces Results From Study Showing Enhanced Activity From Insect Cell-Derived Immunotherapy for Lymphoma
3. Investigational Study Evaluates the Effectiveness of Aripiprazole in Adolescents With Schizophrenia
4. Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls
5. Six-Week Investigational Study In Adults With Major Depressive Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole Therapy With Antidepressants
6. St. Jude Study Shows Effectiveness of Peramivir in Prevention of Mortality in Mouse Model of Avian Influenza H5N1 Virus Infection
7. Study Supports Cost-Effectiveness of Medtronics Spasticity Treatment for Children with Cerebral Palsy
8. FDA MedWatch: Avastin (bevacizumab) and Formation of Tracheoesophageal Fistula in a Recent Clinical Study in Patients with Limited-stage Small Cell Lung Cancer
9. Data Presented at AACR Meeting Shows Peregrines Selective Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical Cancer Models
10. Clinical Results From EntreMeds Panzem NCD and Taxol Breast Cancer Study Presented at ASCO

Post Your Comments:
(Date:12/4/2009)..., Opposes use of imported drugs often stored .... 4 Today, the senior a...t the Dorgan Importation plan encompassed in SA 27...ator Dorgan,s importation amendment is poised to o...stem to be breached, and our health to be endanger...
(Date:12/4/2009)... , HOUSTON, Dec. 4 /PRNewswire/ ...e AcceleDent System , which is an acceleration de...bility of a new Continuing Education course publis...ional education for many industries, including med...t views about orthodontic treatment, a summary of ...
(Date:12/4/2009)..., BETHESDA, Md., Dec. 4 /PRNewswire-FirstCall/ ..."Company") (OTC Bulletin Board: NWBO) announced to...lowed its patent application on a system for autom...the Company,s DCVax® therapeutic cancer vacci...o the very high concentration of dendritic cells (...
Breaking Medicine Technology:RetireSafe Urges Senate to Defeat Senate Amendment 2793 -- Says Senator Dorgan's Drug Importation Plan Puts Seniors at Risk 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Curtain twitching skylarks keep track of strangers through their songs 9716 1Curtain twitching skylarks keep track of strangers through their songs 9716 2U Iowa improves delivery of cancer fighting molecules 9711 1U Iowa improves delivery of cancer fighting molecules 9711 2Sagent Pharmaceuticals Announces Launch of Fluconazole Injection in Premix Ready to Use IV Bags 55516 1Sagent Pharmaceuticals Announces Launch of Fluconazole Injection in Premix Ready to Use IV Bags 55516 2
...as an Adjuvant and Play Key Role in the,Treatment ...20, 2007 /PRNewswire-FirstCall/ --,ImmuneRegen Bio...ces Holdings, Inc. , announced today that data obt...mspera, suggests that the,compound has potential v.... Studies performed in animal models of influenza ...
...20, 2007 -- Clinical studies have,shown (1) simila...diatric influenza patients being treated with Tami...heir influenza. Furthermore,recent data derived f...006 of over 101,000 influenza patients treated wit...taking Tamiflu have shown,that the Tamiflu treated...
Other Medicine Technology:ImmuneRegen BioSciences Announces Promising Data on Homspera,Suggesting Potential as a Co-Therapeutic Agent 2ImmuneRegen BioSciences Announces Promising Data on Homspera,Suggesting Potential as a Co-Therapeutic Agent 3ImmuneRegen BioSciences Announces Promising Data on Homspera,Suggesting Potential as a Co-Therapeutic Agent 4New Data from the US and Japan Support: No Established Causal Link,Between Neuropsychiatric Symptoms and Treatment with Tamiflu US,Databases Indicate Psychiatric Symptoms Lower in Influenza Patients,Taking Tamiflu Versus Those Not Taking Tamiflu 2New Data from the US and Japan Support: No Established Causal Link,Between Neuropsychiatric Symptoms and Treatment with Tamiflu US,Databases Indicate Psychiatric Symptoms Lower in Influenza Patients,Taking Tamiflu Versus Those Not Taking Tamiflu 3New Data from the US and Japan Support: No Established Causal Link,Between Neuropsychiatric Symptoms and Treatment with Tamiflu US,Databases Indicate Psychiatric Symptoms Lower in Influenza Patients,Taking Tamiflu Versus Those Not Taking Tamiflu 4
(Date:12/4/2009)...FirstCall/ -- PD-Rx Pharmaceuticals, Inc. (Pink Sh...for the first quarter ended September 30, 2009, a ...ating income and net income for the quarter were $...ease over the same period last year. ,, Results...les. This trend is expected to continue throughou...
(Date:12/4/2009)...The National Cancer Institute has awarded a $55.4 ... Cancer Research Center to become the nation,s sol...ct Center. ,, The move will create 60 new jobs ...e of its current CIS workforce - once the consolid...ed for March 15, 2010. The Seattle CIS center will...
(Date:12/4/2009)...e (BUSM) researchers at the Slone Epidemiology Cen...ry products have a reduced incidence of uterine le...ack Women,s Health Study, appears in the current i... Uterine fibroids are benign tumors of the uterus...k women than white women. They are the primary ind...
(Date:12/4/2009)...guage patient education leaflets support Joint Com...uage access in healthcare organizations. , ...009 -- Lexi-Comp, Inc., a provider of clinical inf...on materials for healthcare institutions, understa...een the health care professional and the patient w...
(Date:12/4/2009)... Author and Political Analyst Leslie Sanchez proud...Providence Hospital’s “Adopt-a-Family ... $5000 in cash and toy donations for the charity a...match the donation. Toys will be distributed to fa...tal. , Washington, DC (P...
Breaking Medicine News(10 mins):Health News:PD-Rx Pharmaceuticals, Inc. Reports 1st Quarter Earnings 2Health News:Hutchinson Center Wins $55.4 Million Contract to Become Sole Operator of the NCI Cancer Information Service 2Health News:Researchers find increased dairy intake reduces risk of uterine fibroids in black women 2Health News:Lexi-Comp Focused on Improving Patient Communication in Healthcare Institutions Treating Diverse Patient Populations 2Health News:Lexi-Comp Focused on Improving Patient Communication in Healthcare Institutions Treating Diverse Patient Populations 3Health News:Bobby Berk Home and Leslie Sanchez Announce 1st Annual Toy Drive for DC's Neediest Families 2
...vailable in German . , Elimination diets can ...he number of children who have eczema has risen o...condition, which is often associated with an aller...mptoms worse. However, in information published to...
...eo Dramatizes Message That Pulmonary Fibrosis Can ...ith CPF to Find a Cure , , SAN JOSE, Calif., Marc...13 minutes in the U.S., the same number of lives e...nary Fibrosis (CPF) today launched a new public se...
...nt of imaging techniques, the accuracy of preopera...lly, and the preservation of physical function in ... aim of research., A research article to be publ... cancer, and examines the therapeutic efficacy and...
...tine and Tobacco Research Analyzes Trends, Impact ...To date, the majority of research conducted about ...rate to heavy smoking. The March 2009 issue of N...earchers worked together to uncover trends related...
...eople might be dangerous for others, , , F...ve confirmed previously reported genetic factors t... proper dosage of the blood thinner warfarin to pe...lant medication to prevent blood clots and reduce ...
... 20 Shire plc (LSE: SHP, Nasdaq: SHPGY ), the g...ed today a voluntary market withdrawal/recall of t...he lots of DAYTRANA patches affected by this actio...ult, patients and caregivers could have difficulti...
Other Medicine News:Health News:Eczema in children is increasing, but diet is not the cause 2Health News:CPF Launches National PSA to Educate Public on Pulmonary Fibrosis 2Health News:CPF Launches National PSA to Educate Public on Pulmonary Fibrosis 3Health News:New Analysis: Light and Intermittent Smokers Overlooked in Traditional Tobacco Research 2Health News:New Analysis: Light and Intermittent Smokers Overlooked in Traditional Tobacco Research 3Health News:New Analysis: Light and Intermittent Smokers Overlooked in Traditional Tobacco Research 4Health News:Genetics Should Decide Warfarin Dose, Study Reiterates 2Health News:Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced 2Health News:Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced 3Health News:Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced 4Health News:Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced 5
Discovery 90 Ultracentrifuges
...000M does everything you want a floor model centri...ating Power , PR-7000M delivers up to 50% more for...ations are done faster and more efficiently., Tr... 6 liters, PR-7000M accommodates 30 microplates, u...
RC 26 PLUS
RC12BP
Medicine Products: